Department of Biological Sciences, University of Calgary, Calgary, AB, Canada.
Department of Virology, Faculty of Medicine, Iran University of Medical Science, Tehran, Iran.
Microb Pathog. 2020 Oct;147:104390. doi: 10.1016/j.micpath.2020.104390. Epub 2020 Jul 15.
In the current time where we face a COVID-19 pandemic, there is no vaccine or effective treatment at this time. Therefore, the prevention of COVID-19 and the rapid diagnosis of infected patients is crucial.
We searched all relevant literature published up to February 28, 2020. We used Random-effect models to analyze the appropriateness of the pooled results.
Eighty studies were included in the meta-analysis, including 61,742 patients with confirmed COVID-19 infection. 62.5% (95% CI 54.5-79, p < 0.001) of patients had a history of recent travel endemic area or contact with them. The most common symptoms among COVID-19 infected patients were fever 87% (95% CI 73-93, p < 0.001), and cough 68% (95% CI 55.5-74, p < 0.001)), respectively. The laboratory analysis showed that thrombocytosis was present in 61% (95% CI 41-78, p < 0.001) CRP was elevated in 79% (95% CI 65-91, p < 0.001), and lymphopenia in 57.5% (95% CI 42-79, p < 0.001). The most common radiographic signs were bilateral involvement in 81% (95% CI 62.5-87, p < 0.001), consolidation in 73.5% (95% CI 50.5-91, p < 0.001), and ground-glass opacity 73.5% (95% CI 40-90, p < 0.001) of patients. Case fatality rate (CFR) in <15 years old was 0.6%, in >50 years old was 39.5%, and in all range group was 6%.
Fever and cough are the most common symptoms of COVID-19 infection in the literature published to date. Thombocytosis, lymphopenia, and increased CRP were common lab findings although most patients included in the overall analysis did not have laboratory values reported. Among Chinese patients with COVID-19, rates of hospitalization, critical condition, and hospitalization were high in this study, but these findings may be biased by reporting only confirmed cases.
在当前我们面临 COVID-19 大流行的时代,目前尚无疫苗或有效治疗方法。因此,预防 COVID-19 和快速诊断感染患者至关重要。
我们搜索了截至 2020 年 2 月 28 日发表的所有相关文献。我们使用随机效应模型分析汇总结果的适宜性。
共有 80 项研究纳入荟萃分析,包括 61742 例确诊 COVID-19 感染患者。62.5%(95%置信区间 54.5-79,p<0.001)的患者有近期前往流行地区旅行或接触的病史。COVID-19 感染患者最常见的症状是发热 87%(95%置信区间 73-93,p<0.001),咳嗽 68%(95%置信区间 55.5-74,p<0.001)。实验室分析显示血小板增多症占 61%(95%置信区间 41-78,p<0.001),CRP 升高占 79%(95%置信区间 65-91,p<0.001),淋巴细胞减少占 57.5%(95%置信区间 42-79,p<0.001)。最常见的影像学征象是双侧受累占 81%(95%置信区间 62.5-87,p<0.001),实变占 73.5%(95%置信区间 50.5-91,p<0.001),磨玻璃影占 73.5%(95%置信区间 40-90,p<0.001)。年龄<15 岁的病死率(CFR)为 0.6%,年龄>50 岁的病死率为 39.5%,所有年龄段的病死率为 6%。
发热和咳嗽是迄今为止发表的文献中 COVID-19 感染的最常见症状。虽然大多数患者的实验室值没有报告,但血小板增多症、淋巴细胞减少症和 CRP 升高是常见的实验室发现。在本研究中,中国 COVID-19 患者的住院率、重症率和住院率均较高,但这些发现可能因仅报告确诊病例而存在偏差。